Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_032bb277dfe3c4171ed15135e7778ca0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-4055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-491 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-40 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38 |
filingDate |
2020-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeecbeb43cb757c18023ae61e4511e9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cfc3e7425e7c63df3b5cd29e68a911d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc79374448fe0ba7950f9b9bce812091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fef19496219f50fd6000a33c6592f42d |
publicationDate |
2022-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20220079572-A |
titleOfInvention |
THERAPEUTIC PROTEIN COMPOSITIONS AND METHODS |
abstract |
The composition of the present invention provides a Therapeutic protein having less than 2% contamination by the denatured form of the Therapeutic protein. Such compositions provide improved specific activity and improved stability upon storage and/or in serum over corresponding therapeutic protein preparations produced by conventional isolation methods. |
priorityDate |
2019-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |